The Medicines (Products for Human Use) (Fees) Regulations 2016

Fee for advice on labelling or leafletsU.K.

This section has no associated Explanatory Memorandum

8.  The fee payable by the holder of one or more marketing authorisations with whom the licensing authority holds a meeting in order to provide advice on proposed changes to the labelling or the package leaflets of the medicinal products to which those authorisations relate, is £2,201.